 Jennifer Armstrong
Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 12 | 2019 | 1022 | 1.080 |
Why?
| | Infant, Newborn, Diseases | 4 | 2019 | 104 | 1.010 |
Why?
| | Brain Ischemia | 6 | 2018 | 299 | 0.500 |
Why?
| | Fetal Membranes, Premature Rupture | 1 | 2014 | 34 | 0.460 |
Why?
| | Chorioamnionitis | 1 | 2014 | 36 | 0.460 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2015 | 223 | 0.440 |
Why?
| | Interleukin-8 | 1 | 2014 | 237 | 0.440 |
Why?
| | Cerebral Arterial Diseases | 4 | 2016 | 42 | 0.430 |
Why?
| | Fetal Blood | 1 | 2014 | 270 | 0.410 |
Why?
| | Interleukin-1beta | 1 | 2014 | 370 | 0.400 |
Why?
| | Nervous System Diseases | 1 | 2014 | 256 | 0.380 |
Why?
| | Rare Diseases | 1 | 2011 | 89 | 0.360 |
Why?
| | Interleukin-6 | 1 | 2014 | 676 | 0.360 |
Why?
| | Asphyxia Neonatorum | 1 | 2010 | 15 | 0.340 |
Why?
| | Subarachnoid Hemorrhage | 2 | 2009 | 60 | 0.330 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1140 | 0.330 |
Why?
| | Magnetic Resonance Imaging | 3 | 2019 | 3053 | 0.320 |
Why?
| | Ultrasonography, Doppler, Transcranial | 1 | 2009 | 42 | 0.320 |
Why?
| | Cerebral Infarction | 1 | 2009 | 39 | 0.320 |
Why?
| | Infant, Newborn | 10 | 2019 | 5047 | 0.310 |
Why?
| | Placenta | 1 | 2014 | 628 | 0.310 |
Why?
| | Cerebral Hemorrhage | 1 | 2009 | 96 | 0.300 |
Why?
| | Infant, Premature, Diseases | 1 | 2009 | 89 | 0.290 |
Why?
| | Developmental Disabilities | 1 | 2010 | 237 | 0.280 |
Why?
| | Anemia, Sickle Cell | 1 | 2009 | 215 | 0.260 |
Why?
| | Cognition Disorders | 1 | 2010 | 476 | 0.250 |
Why?
| | Brain | 3 | 2015 | 2371 | 0.250 |
Why?
| | Brain Injuries | 1 | 2010 | 461 | 0.240 |
Why?
| | Cohort Studies | 6 | 2014 | 4895 | 0.210 |
Why?
| | Temporal Lobe | 1 | 2019 | 79 | 0.160 |
Why?
| | Intracranial Hemorrhages | 1 | 2019 | 76 | 0.160 |
Why?
| | Prospective Studies | 6 | 2018 | 6220 | 0.150 |
Why?
| | Research Design | 2 | 2012 | 928 | 0.130 |
Why?
| | Fibrin Fibrinogen Degradation Products | 2 | 2012 | 80 | 0.120 |
Why?
| | Male | 15 | 2019 | 55609 | 0.120 |
Why?
| | Child | 12 | 2018 | 18422 | 0.120 |
Why?
| | Epilepsy | 1 | 2018 | 278 | 0.120 |
Why?
| | Humans | 22 | 2019 | 114709 | 0.110 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2014 | 55 | 0.110 |
Why?
| | Female | 14 | 2019 | 59523 | 0.110 |
Why?
| | Reproducibility of Results | 3 | 2016 | 2765 | 0.110 |
Why?
| | Hyperhomocysteinemia | 1 | 2013 | 24 | 0.110 |
Why?
| | Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2013 | 34 | 0.110 |
Why?
| | Apoprotein(a) | 1 | 2013 | 5 | 0.110 |
Why?
| | Cerebrovascular Disorders | 1 | 2014 | 82 | 0.110 |
Why?
| | Pediatrics | 2 | 2012 | 981 | 0.100 |
Why?
| | Lipoprotein(a) | 1 | 2013 | 51 | 0.100 |
Why?
| | Thromboembolism | 1 | 2013 | 92 | 0.100 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 797 | 0.100 |
Why?
| | Migraine with Aura | 1 | 2012 | 10 | 0.100 |
Why?
| | Inflammation | 2 | 2014 | 2480 | 0.100 |
Why?
| | Gestational Age | 1 | 2014 | 760 | 0.100 |
Why?
| | Edema | 1 | 2012 | 119 | 0.090 |
Why?
| | Child, Preschool | 7 | 2018 | 9119 | 0.090 |
Why?
| | Sensitivity and Specificity | 1 | 2015 | 1694 | 0.090 |
Why?
| | Fibrinolytic Agents | 1 | 2012 | 234 | 0.090 |
Why?
| | Blood Coagulation Disorders | 1 | 2012 | 197 | 0.090 |
Why?
| | Risk Factors | 6 | 2018 | 8634 | 0.090 |
Why?
| | Herpesvirus 3, Human | 1 | 2014 | 378 | 0.090 |
Why?
| | Pia Mater | 1 | 2009 | 4 | 0.090 |
Why?
| | Moyamoya Disease | 1 | 2009 | 14 | 0.080 |
Why?
| | Herpes Zoster | 1 | 2014 | 331 | 0.080 |
Why?
| | Dwarfism | 1 | 2009 | 15 | 0.080 |
Why?
| | Thrombosis | 1 | 2012 | 298 | 0.080 |
Why?
| | Thrombophilia | 1 | 2009 | 67 | 0.080 |
Why?
| | Intracranial Arteriovenous Malformations | 1 | 2009 | 51 | 0.080 |
Why?
| | Microcephaly | 1 | 2009 | 51 | 0.080 |
Why?
| | Health Maintenance Organizations | 1 | 2009 | 93 | 0.080 |
Why?
| | Transfusion Reaction | 1 | 2009 | 65 | 0.080 |
Why?
| | Intracranial Aneurysm | 1 | 2009 | 91 | 0.080 |
Why?
| | Fetal Diseases | 1 | 2009 | 147 | 0.080 |
Why?
| | Neurosurgical Procedures | 1 | 2009 | 152 | 0.080 |
Why?
| | California | 1 | 2009 | 353 | 0.070 |
Why?
| | Young Adult | 4 | 2018 | 10472 | 0.070 |
Why?
| | Neurology | 1 | 2008 | 85 | 0.070 |
Why?
| | Cytokines | 1 | 2014 | 1841 | 0.070 |
Why?
| | Regression Analysis | 1 | 2009 | 945 | 0.070 |
Why?
| | Proportional Hazards Models | 1 | 2009 | 1075 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2013 | 3004 | 0.060 |
Why?
| | Neuropsychological Tests | 1 | 2010 | 927 | 0.060 |
Why?
| | Severity of Illness Index | 2 | 2010 | 2540 | 0.060 |
Why?
| | Pregnancy | 2 | 2014 | 5520 | 0.060 |
Why?
| | Infant | 6 | 2018 | 7964 | 0.060 |
Why?
| | Adolescent | 6 | 2018 | 17855 | 0.060 |
Why?
| | Predictive Value of Tests | 1 | 2009 | 1796 | 0.060 |
Why?
| | Cross-Sectional Studies | 2 | 2016 | 4410 | 0.060 |
Why?
| | Biomarkers | 2 | 2012 | 3408 | 0.050 |
Why?
| | Circumcision, Male | 1 | 2002 | 17 | 0.050 |
Why?
| | Retrospective Studies | 3 | 2019 | 12556 | 0.050 |
Why?
| | Pain, Postoperative | 1 | 2002 | 191 | 0.040 |
Why?
| | Cerebral Angiography | 2 | 2009 | 109 | 0.040 |
Why?
| | Adult | 3 | 2014 | 30554 | 0.040 |
Why?
| | Colorado | 3 | 2013 | 4100 | 0.040 |
Why?
| | Follow-Up Studies | 2 | 2018 | 4411 | 0.030 |
Why?
| | Incidence | 2 | 2013 | 2313 | 0.030 |
Why?
| | Neuroimaging | 1 | 2016 | 249 | 0.030 |
Why?
| | Treatment Outcome | 3 | 2013 | 9088 | 0.030 |
Why?
| | Prognosis | 2 | 2012 | 3330 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2014 | 372 | 0.030 |
Why?
| | Quality Control | 1 | 2012 | 144 | 0.030 |
Why?
| | Mutation | 2 | 2014 | 3346 | 0.030 |
Why?
| | Multicenter Studies as Topic | 1 | 2012 | 249 | 0.020 |
Why?
| | Delphi Technique | 1 | 2011 | 160 | 0.020 |
Why?
| | Fibrinolysis | 1 | 2013 | 158 | 0.020 |
Why?
| | Observer Variation | 1 | 2011 | 296 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2013 | 610 | 0.020 |
Why?
| | Risk | 1 | 2013 | 812 | 0.020 |
Why?
| | Recurrence | 1 | 2012 | 935 | 0.020 |
Why?
| | Factor VIII | 1 | 2009 | 53 | 0.020 |
Why?
| | Pregnancy Trimester, Third | 1 | 2009 | 79 | 0.020 |
Why?
| | Consensus | 1 | 2011 | 539 | 0.020 |
Why?
| | Anastomosis, Surgical | 1 | 2009 | 136 | 0.020 |
Why?
| | Animals | 1 | 2010 | 31709 | 0.020 |
Why?
| | Genotype | 1 | 2013 | 1760 | 0.020 |
Why?
| | Age of Onset | 1 | 2009 | 446 | 0.020 |
Why?
| | Ultrasonography, Prenatal | 1 | 2009 | 236 | 0.020 |
Why?
| | Abnormalities, Multiple | 1 | 2009 | 178 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2012 | 1342 | 0.020 |
Why?
| | Cerebral Arteries | 1 | 2008 | 55 | 0.020 |
Why?
| | Magnetic Resonance Angiography | 1 | 2009 | 220 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2009 | 362 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2012 | 1214 | 0.020 |
Why?
| | Thrombolytic Therapy | 1 | 2008 | 117 | 0.020 |
Why?
| | Prevalence | 1 | 2013 | 2251 | 0.020 |
Why?
| | Physical Therapy Modalities | 1 | 2008 | 265 | 0.020 |
Why?
| | Algorithms | 1 | 2011 | 1470 | 0.010 |
Why?
| | Registries | 1 | 2011 | 1768 | 0.010 |
Why?
| | Age Factors | 1 | 2008 | 2894 | 0.010 |
Why?
| | Practice Guidelines as Topic | 1 | 2008 | 1395 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2009 | 2286 | 0.010 |
Why?
| | Time Factors | 1 | 2009 | 6116 | 0.010 |
Why?
| | United States | 1 | 2013 | 12186 | 0.010 |
Why?
|
|
Armstrong's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|